Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer boosts pre-clinical oncology pipeline

August 8, 2008
Research and Development

Bayer Schering Pharma has acquired two potential cancer drugs and a range of oncology compounds from Nycomed in a deal …

News

Genentech won’t surrender independence without a fight

August 8, 2008
Sales and Marketing

Roche has moved to end its 'arm's length' arrangement with Genentech, offering to buy the remaining shares in the company …

News

NHS ‘Integrated Care’: from buzzword to reality?

August 8, 2008

Primary care professionals have urged the government to fulfil its promise of a new commissioner-led health service, and call for …

News

NICE set to deny access to kidney cancer drugs

August 8, 2008
Sales and Marketing

Four treatments for advanced kidney cancer have been rejected by NICE even though they show significant clinical benefits. The Institute's …

News

Tracleer wins wider EU licence

August 8, 2008
Sales and Marketing

Actelion's Tracleer (bosentan) has been approved in Europe to treat patients with mildly symptomatic pulmonary arterial hypertension (PAH). The move …

News

Actemra close to US approval

August 8, 2008
Sales and Marketing

US regulars have recommended Roche's Actemra (tocilizumab) be approved to treat adults with moderate to severe rheumatoid arthritis (RA). The …

News

Latest news from Datamonitor

August 5, 2008
Research and Development, Sales and Marketing

Biovest/Accentia's BiovaxID revives hope for therapeutic cancer vaccines Biovest, a subsidiary of Accentia, has announced positive data from a pivotal …

News

Currency lifts Wyeth to 5% growth

July 31, 2008
Sales and Marketing

Wyeth saw revenues increase 5% in the second quarter of the year to $5.9 billion, contributing to six month sales …

News

Sanofi boosts vaccines pipeline with Acambis acquisition

July 31, 2008
Sales and Marketing

Sanofi-Aventis has snapped up UK biotech Acambis for £276 million, gaining access to an early-stage pipeline of vaccine candidates targeting …

News

Lilly’s second quarter marred by prasugrel delay

July 31, 2008
Sales and Marketing

A delay to a key new product took the shine off Lilly's strong second quarter, which saw sales increase 11% …

News

Sanofi sees off rival for Czech generic company

July 31, 2008
Sales and Marketing

Sanofi-Aventis' proposed takeover of Zentiva is a step closer to success after its only rival for the Czech generics company …

News

Sanofi underperforms in second quarter

July 31, 2008
Sales and Marketing

Sanofi-Aventis had a below par second quarter and faces a generic threat to sales of top-selling drug Plavix in Germany. …

News

AstraZeneca boosted by Crestor sales

July 31, 2008
Sales and Marketing

AstraZeneca's second quarter sales increased by 9% to $8 billion, as it rode out a 4% drop in US sales …

News

A new kind of patient advocate

July 30, 2008
Sales and Marketing Cancer, campaigner, market access, patient

When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …

Feature

Scepticism over

July 29, 2008

NICE will receive a record £100 million from the government in attempt to end the UK's postcode lottery and speed …

News

The organisational generation gap

July 28, 2008
Business Services careers, generations, recruitment

If you look at your organisation carefully, it is likely you will find three or even four generations represented among …

Feature

Latest news from Datamonitor

July 28, 2008
Sales and Marketing Genentech, Roche

Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …

News

Pharma-Patient group relationships

July 24, 2008
Research and Development, Sales and Marketing industry relations, patient groups, pharma

In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …

Feature

Generics giant formed as Teva acquires Barr

July 24, 2008
Sales and Marketing generics

Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …

News

Roche acquires gene therapy specialists Mirus

July 24, 2008
Sales and Marketing

Roche has bought Mirus Bio for $125 million, a move which it believes will put it at the forefront of …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026